By


Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Debuted as a public company and strengthened liquidity position with $95.1 million in gross proceeds from the business combination with Chardan Healthcare Acquisition 2 Corp and concurrent PIPE financing

Released topline preclinical data demonstrating feasibility of REN-001 to transduce a large animal heart via local infusion at low vector doses

Strengthened company leadership with key appointments including Matthew Killeen, Ph.D., as CSO, and Elizabeth White, Ph.D., as CBO and SVP of Operations

See more here

By


Data from ImmunoGenesis’ Lead Programs Presented in Six Posters at Society for Immunotherapy of Cancer (SITC) Conference

See more here

By


Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results 

See more here

By


Wellsheet Collaborates with Horizon to Provide Clinicians with a Single View of Key Data and Insights within their EHR Workflow 

New Jersey Health Providers Can Access a Near Real-Time Comprehensive View of Patients’ Medical History

See more here

By


Venatorx Pharmaceuticals Announces Collaboration with Roche to Develop New Class of Antibiotics targeting WHO Critical Priority Pathogen 

Development of novel antibiotics to circumvent antimicrobial resistance and address increasing threat of superbugs

See more here

By


Phrase Health Announces $3M Investment from Health IT Leaders: LionBird, Vizient, Inc., and BioAdvance 

The new investment will enhance growth initiatives, accelerate development, and support additional research to enhance platform capabilities.

See more here

By


Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

See more here

By


Annovis Bio Announces Positive Phase Two Efficacy Data for Treatment of Parkinson’s Disease

Data Shows Statistically Significant Improvements in Speed and Motor Function in PD Patients

Annovis Bio to Request Meeting with FDA on Next Steps in Clinical Development

Investor Conference Call to be Hosted Tuesday, October 5th, 2021, at 9:00 am ET

See more here

By


Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations

Dr. Dhanasekharan joins Renovacor with extensive experience overseeing development, manufacturing and supply operations for biologics including AAV gene therapies

See more here